PNEUMOCOCCAL VACCINES
Clinical trials for PNEUMOCOCCAL VACCINES explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL VACCINES trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL VACCINES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine targets 26 pneumococcal strains in early trial
⭐️ VACCINE ⭐️ CompletedThis completed Phase I/II trial tested a new 26-valent pneumococcal conjugate vaccine in 450 people aged 2 months and older. The goal was to check safety and how well the vaccine triggers an immune response compared to existing vaccines. Researchers monitored side effects and ant…
Matched conditions: PNEUMOCOCCAL VACCINES
Phase: PHASE1, PHASE2 • Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:01 UTC
-
New 25-Valent pneumonia vaccine shows promise in phase 2 trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine designed to protect against 25 types of pneumococcal bacteria, which can cause pneumonia and other serious infections. About 220 healthy adults aged 18 to 49 received either the new vaccine or an existing one to compare safety and immune response. …
Matched conditions: PNEUMOCOCCAL VACCINES
Phase: PHASE2 • Sponsor: Inventprise Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:02 UTC
-
New 24-Strain pneumonia vaccine shows promise in infant trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called VAX-24, which targets 24 types of pneumococcal bacteria, in 802 healthy infants. The babies received four doses at 2, 4, 6, and 12-15 months old, alongside routine vaccines. The goal was to check safety and how well the vaccine triggers an i…
Matched conditions: PNEUMOCOCCAL VACCINES
Phase: PHASE2 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 16:37 UTC